Jingbo Wang

6PUBLICATIONS
3CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTransplantation immunologyCardiovascular medicine and haematology not elsewhere classifiedRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 17, 2026
A panel of ST2, Reg3α, Elafin, and TNFR1: Predictive value for acute GvHD and outcomes in hematological malignancy patients post allo-HSCT.

|Apr 11, 2024
FLT-3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation.

Song Xue, Wenqiu Huang, Yongping Zhang

|Dec 13, 2023
Severe graft-versus-host disease post allogeneic hematopoietic stem cell transplantation due to loss of HLA heterozygosity in recipient lymphocytes after full graft rejection.

Song Xue, Lili Miao, Zimu Gong

|Nov 22, 2022
FLT3 inhibitors as maintenance therapy post allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with FLT3 mutations: A meta-analysis.

Xinhong Fei, Shuqin Zhang, Jiangying Gu

|Apr 20, 2022
Rapid response to avapritinib of acute myeloid leukemia with t(8;21) and KIT mutation relapse post allo-HSCT.

Song Xue, Wenqiu Huang, Fuhong Liu

|Aug 25, 2021
MRD abnormal expression predict poor outcomes for refractory or relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Qi Hao, Xinyue Liu, Yongping Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Song Xue

1 joint publications

Wenqiu Huang

1 joint publications

Qi Hao